Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stability of cefiderocol against clinically significant broad-spectrum oxacillinases.

× No keyword cloud information.

12 in total

Review 1. OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.

Authors: Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope
Journal: Antimicrob Agents Chemother Date: 2022-07-20 Impact factor: 5.938

Review 2. Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance.

Authors: Stamatis Karakonstantis; Maria Rousaki; Evangelos I Kritsotakis
Journal: Antibiotics (Basel) Date: 2022-05-27

3. Impact of Acquired Broad-Spectrum β-Lactamases on Susceptibility to Cefiderocol and Newly Developed β-Lactam/β-Lactamase Inhibitor Combinations in Escherichia coli and Pseudomonas aeruginosa.

Authors: Laurent Poirel; Jose-Manuel Ortiz de la Rosa; Mustafa Sadek; Patrice Nordmann
Journal: Antimicrob Agents Chemother Date: 2022-03-22 Impact factor: 5.938

4. Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin.

Authors: Takafumi Sato; Kenji Yamawaki
Journal: Clin Infect Dis Date: 2019-11-13 Impact factor: 9.079

5. In Vitro Activity of Cefiderocol Against a Broad Range of Clinically Important Gram-negative Bacteria.

Authors: Yoshinori Yamano
Journal: Clin Infect Dis Date: 2019-11-13 Impact factor: 9.079

6. Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens - The International, Multicenter, Randomized, Open-Label, Phase 3 CREDIBLE-CR Study.

Authors: Matteo Bassetti; Mari Ariyasu; Bruce Binkowitz; Tsutae Den Nagata; Roger M Echols; Yuko Matsunaga; Kiichiro Toyoizumi; Yohei Doi
Journal: Infect Drug Resist Date: 2019-11-21 Impact factor: 4.003

Review 7. Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data.

Authors: Daniele Roberto Giacobbe; Eugenio Ciacco; Corrado Girmenia; Federico Pea; Gian Maria Rossolini; Giovanni Sotgiu; Carlo Tascini; Mario Tumbarello; Pierluigi Viale; Matteo Bassetti
Journal: Infect Drug Resist Date: 2020-12-29 Impact factor: 4.003

8. Contribution of PER-Type and NDM-Type β-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii.

Authors: Laurent Poirel; Mustafa Sadek; Patrice Nordmann
Journal: Antimicrob Agents Chemother Date: 2021-07-12 Impact factor: 5.191

Review 9. New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives.

Authors: Marco Terreni; Marina Taccani; Massimo Pregnolato
Journal: Molecules Date: 2021-05-02 Impact factor: 4.411

Review 10. Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions.

Authors: Kathleen Tompkins; David van Duin
Journal: Eur J Clin Microbiol Infect Dis Date: 2021-06-24 Impact factor: 5.103